11 ways to support cancer patients and survivors this holiday season
Holiday celebrations look a lot different this year because of the coronavirus (COVID-19) pandemic. It’s a difficult time for everyone, but it can be especially hard for people with weaker immune systems, like our cancer patients and survivors.
“It’s safest for our immunocompromised patients to limit their exposure to people outside of their household, so this holiday season may feel like a very lonely time,” says our infectious...
Multiple myeloma: When to treat and when to wait
Multiple myeloma is a cancer that develops in a type of white blood cell called plasma cells. Normally, these cells help us make antibodies...
How molecular testing and targeted therapy are changing B-cell lymphoma treatment
B-cell lymphoma isn’t one disease. There are about 63 subtypes, with diffuse large B-cell lymphoma (DLBCL) being the most common. A chemotherapy...
Clinical trials glossary: 12 terms to know
New and better cancer treatments are discovered through clinical trials. By joining one, patients get access to the most cutting-edge treatments.
If you’re considering enrolling in a clinical trial, or if you’re trying to understand the results from one, you may be wondering what words, like Phase, mean. We spoke with Funda Meric-Bernstam, M.D., to learn what you should know to understand clinical trials.
What are clinical...
Monoclonal antibodies and cancer treatment: What to know
Last updated Jan. 11, 2022.
First emerging almost three decades ago, monoclonal antibodies are changing the way doctors treat cancer...
Predicting and preventing CAR T cell therapy side effects in lymphoma patients
CAR T cell therapy has changed the way aggressive B-cell lymphoma is treated. Previously, when patients had a second recurrence after receiving...